Dr. Susan B. Kesmodel, MD

Dr. Kesmodel practices at Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County.

Dr. Kesmodel's NPI, 1093814758, was assigned on September 21, 2006. Dr. Kesmodel graduated from Perelman School of Medicine - Philadelphia in 1998. Dr. Kesmodel holds Florida license ME131403.

Dr. Kesmodel's primary practice is Jackson Memorial Hospital, at 1611 Nw 12th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 585-1111.

Dr. Kesmodel's primary practice is Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County. Dr. Kesmodel is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Kesmodel to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kesmodel practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Kesmodel's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Kesmodel is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Kesmodel's licenses on file in 4 states: Florida, Maryland, Texas and Pennsylvania.

Dmand AI lists mastectomy among the conditions Dr. Kesmodel treats.

CMS data shows 117 Medicare services from Dr. Kesmodel across 3 procedure codes in 2024, all of them office visits, for 98 Medicare patients. Medicare paid $8,737 for them.

CMS counts 98 Medicare patients who saw Dr. Kesmodel in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have cancer, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kesmodel's median patient age at 63, with 98% women.

In 2024, Dr. Kesmodel wrote 50 Medicare Part D claims for 32 patients. 100% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $47 in total drug cost. In 2023, CMS named 27 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Kesmodel for performance year 2024, reported as part of a group. Dr. Kesmodel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kesmodel as offering telehealth. CMS counts 40 procedures of mastectomy by Dr. Kesmodel, more than 91% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 78 papers to Dr. Kesmodel, published from 2003 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Breast Neoplasms, Mastectomy and Sentinel Lymph Node Biopsy. Dr. Kesmodel has published most often in Ann Surg Oncol. Dr. Kesmodel's most frequent co-authors are Elizabeth May Nichols, MD, Kristin Emilia Rojas, MD and Katherine Hanna Tkaczuk, MD.

Dmand AI links Dr. Kesmodel to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating and Sarcopenia.

CMS Open Payments shows 24 general payments to Dr. Kesmodel from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. AxoGen paid the most, $285.

Dmand AI lists 2 awards for Dr. Kesmodel, most recently CMS Stage 1 EHR in 2013.

Dr. Kesmodel graduated from Perelman School of Medicine - Philadelphia in 1998. Dr. Kesmodel is a member of ACS.

Dr. Kesmodel is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.